viimane versioon :
29/10/2024
Antihüpertensiivne ravim   Lisinopril  
suukaudne lahus
Stabiilsust ravimpreparaadid Stabiilsust mõjutavad tegurid stabiilsust mõjutavad faktorid Sobimatus Viited pdf
   keemiline struktuur  

suukaudne lahus
Viited   suukaudne lahus   Viited : Lisinopril  
tüüp avaldamine
2389 ajaleht Thompson KC, Zhao Z, Mazakas JM, Beasley CA, Reed RA, Moser CL.
Characterization of an extemporaneous liquid formulation of lisinopril
Am J Health-Syst Pharm 2003 ; 60: 69-74.
2549 ajaleht Nahata MC, Morosco RS.
Stability of Lisinopril in Two Liquid Dosage Forms
Ann Pharmacotherapy 2004 ;38:396-399.
2665 ajaleht Webster AA, English BA, Rose DJ.
The stability of lisinopril as an extemporaneous syrup.
Int J Pharm Compound 1997 ; 1: 352-353.
2680 ajaleht Rose DJ, Webster AA, English BA.
Stability of lisinopril syrup (2 mg/ml) extemporaneously compounded from tablets.
Int J Pharm Compound 2000 : 398-399.
3902 ajaleht Polonini Hudson C, Loures Sharlene,de Araujo Edson Peter, Brand?o Marcos Ant?nio F, Ferreira Anderson O.
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions.
Int J Pharm Compound 2016 ; 20, 5 : 426-434.

  Mentions Légales